DE69636040D1 - Immunität gegen rtx toxine aus actinobacillus pleuropneumoniae - Google Patents

Immunität gegen rtx toxine aus actinobacillus pleuropneumoniae

Info

Publication number
DE69636040D1
DE69636040D1 DE69636040T DE69636040T DE69636040D1 DE 69636040 D1 DE69636040 D1 DE 69636040D1 DE 69636040 T DE69636040 T DE 69636040T DE 69636040 T DE69636040 T DE 69636040T DE 69636040 D1 DE69636040 D1 DE 69636040D1
Authority
DE
Germany
Prior art keywords
immunity against
actinobacillus pleuropneumoniae
rtx toxins
rtx
toxins
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69636040T
Other languages
English (en)
Other versions
DE69636040T2 (de
Inventor
Thomas Prideaux
Leslie Hodgson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Commonwealth Scientific and Industrial Research Organization CSIRO
Pig Research and Development Corp
Original Assignee
Commonwealth Scientific and Industrial Research Organization CSIRO
Pig Research and Development Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=3790639&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE69636040(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Commonwealth Scientific and Industrial Research Organization CSIRO, Pig Research and Development Corp filed Critical Commonwealth Scientific and Industrial Research Organization CSIRO
Publication of DE69636040D1 publication Critical patent/DE69636040D1/de
Application granted granted Critical
Publication of DE69636040T2 publication Critical patent/DE69636040T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/102—Pasteurellales, e.g. Actinobacillus, Pasteurella; Haemophilus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/285—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Pasteurellaceae (F), e.g. Haemophilus influenza
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Microbiology (AREA)
  • Public Health (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Mycology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Communicable Diseases (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Toxicology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DE69636040T 1995-11-02 1996-11-01 Immunität gegen rtx toxine aus actinobacillus pleuropneumoniae Expired - Fee Related DE69636040T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AUPN631495 1995-11-02
AUPN6314A AUPN631495A0 (en) 1995-11-02 1995-11-02 Vaccine and biological vector(I)
PCT/AU1996/000686 WO1997016532A1 (en) 1995-11-02 1996-11-01 Immunity against actinobacillus pleuropneumoniae's rtx toxins apx

Publications (2)

Publication Number Publication Date
DE69636040D1 true DE69636040D1 (de) 2006-05-24
DE69636040T2 DE69636040T2 (de) 2006-12-07

Family

ID=3790639

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69636040T Expired - Fee Related DE69636040T2 (de) 1995-11-02 1996-11-01 Immunität gegen rtx toxine aus actinobacillus pleuropneumoniae

Country Status (12)

Country Link
US (1) US6472183B2 (de)
EP (1) EP0861319B1 (de)
JP (1) JP3905128B2 (de)
KR (1) KR100448225B1 (de)
AU (2) AUPN631495A0 (de)
BR (2) BR9610848B8 (de)
CA (1) CA2236699C (de)
DE (1) DE69636040T2 (de)
DK (1) DK0861319T3 (de)
ES (1) ES2262159T3 (de)
NZ (1) NZ320026A (de)
WO (1) WO1997016532A1 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPN631395A0 (en) * 1995-11-02 1995-11-23 Commonwealth Scientific And Industrial Research Organisation Vaccine and biological vector(II)
HU226219B1 (en) * 1996-05-31 2008-06-30 Intervet Int Bv Live attenuated rtx-producing bacteria of the family pasteurellaceae
EP1518558B1 (de) * 1997-04-10 2013-11-20 Intervet International B.V. Impfstoffe gegen Actinobacillus pleuropneumoniae Infektion, die hochreines Toxin enthalten
US20040009936A1 (en) * 1999-05-03 2004-01-15 Tang De-Chu C. Vaccine and drug delivery by topical application of vectors and vector extracts
ES2251268B1 (es) * 2002-07-15 2007-07-01 Universidad Del Pais Vasco Euskal Herriko Unibertsitatea Peptidos derivados de toxinas rtx para la proteccion de celulas del ataque por toxinas bacterianas.
ES2233145B1 (es) * 2002-11-20 2006-07-16 Laboratorios Hipra, S.A. Vacuna viva atenuada contra la pleuroneumonia porcina.
US20040209370A1 (en) * 2002-12-19 2004-10-21 Wonchul Suh Method for chromosomal engineering
US10183069B2 (en) 2011-03-21 2019-01-22 Altimmune Inc. Rapid and prolonged immunologic-therapeutic
ES2416154B1 (es) 2011-11-09 2015-04-01 Laboratorios Hipra, S.A. Cepa viva atenuada de Actinobacillus pleuropneumoniae
CN102517232B (zh) * 2011-12-15 2013-07-31 中国农业科学院哈尔滨兽医研究所 一种不含抗性标记的猪胸膜肺炎放线杆菌双基因缺失株、其构建方法及应用
US11149246B2 (en) * 2016-12-29 2021-10-19 Shoreline Biome, Llc Methods for cell lysis and preparation of high molecular weight DNA from modified cells
WO2019121861A1 (en) * 2017-12-20 2019-06-27 Intervet International B.V. A vaccine to protect a pig against actinobacillus pleuropneumoniae
EP3689373A1 (de) 2019-01-30 2020-08-05 IDT Biologika GmbH Inaktivierte apxia, apxiia und apxiiia toxine
GB202011902D0 (en) 2020-07-30 2020-09-16 Imperial College Innovations Ltd Antinobacillus pleuropneumoniae vaccines

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5641653A (en) * 1989-10-31 1997-06-24 The Texas A&M University System DNA encoding Actinobacillus pleuropneumoniae hemolysin
ES2171393T3 (es) * 1991-12-23 2002-09-16 Dimminaco Ag Vacuna contra la serpulina hyodysenteriae.
CA2170839A1 (en) * 1995-03-01 1996-09-02 Janet Macinnes Bacterial preparations, method for producing same, and their use as vaccines
EP0810283A3 (de) * 1996-05-31 1997-12-10 Akzo Nobel N.V. Lebende attenuierte RTX-produzierende Bakterien aus der Familie pasteurellaceae
AU6969798A (en) * 1997-04-15 1998-11-11 Baylor College Of Medicine (pasteurella haemolytica) vaccine

Also Published As

Publication number Publication date
KR19990067268A (ko) 1999-08-16
CA2236699C (en) 2009-08-11
WO1997016532A1 (en) 1997-05-09
AU7268696A (en) 1997-05-22
BR9610848A (pt) 2001-10-09
US20020022035A1 (en) 2002-02-21
EP0861319A4 (de) 2001-10-10
EP0861319A1 (de) 1998-09-02
JPH11514878A (ja) 1999-12-21
AU717769B2 (en) 2000-03-30
DK0861319T3 (da) 2006-09-04
AUPN631495A0 (en) 1995-11-23
CA2236699A1 (en) 1997-05-09
EP0861319B1 (de) 2006-04-12
ES2262159T3 (es) 2006-11-16
BR9610848B8 (pt) 2014-08-05
DE69636040T2 (de) 2006-12-07
US6472183B2 (en) 2002-10-29
KR100448225B1 (ko) 2005-06-17
JP3905128B2 (ja) 2007-04-18
NZ320026A (en) 1999-10-28

Similar Documents

Publication Publication Date Title
NO961137D0 (no) Intravenöst applikerbare nano-suspensjoner
NO963625D0 (no) Kateter
EE9800040A (et) Inhalaator
DE69519221D1 (de) Abtastgerät
DE69632659D1 (de) Vielschichtvaristor
DE69636040D1 (de) Immunität gegen rtx toxine aus actinobacillus pleuropneumoniae
DK0830166T3 (da) Inhalationsapparat
PT824535E (pt) Cefalosporinas antibacterianas
DE69602107D1 (de) Mehrschichtiger Fotorezeptor
DE69610177D1 (de) Lärmschutzwand
DE69605620D1 (de) Konferenzsystem
DE69605623D1 (de) Mehrschichtrohr
NO980632L (no) Sideveis tilbakevending gjennom rör
DE69632158D1 (de) Drehverbinder
DE69612344D1 (de) Kodierte Linsenrastermedien
DE69614346D1 (de) Extrusionsmaschine
FR2732345B1 (fr) Peptide antibacterien
DE59700612D1 (de) Personendurchgangssperre
KR970013827U (ko) 차음벽
KR950003859U (ko) 도로용 방음벽
KR970009922U (ko) 담장
KR970027574U (ko) 차단막 부착식 절단기
NO950095D0 (no) Stöyskjerm
SE9501299D0 (sv) Barriär säng
ES1032280Y (es) Cercado mejorado

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee